Guard Therapeutics International AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Göran Forsberg, was filed 13 Oct 2020.
Guard Therapeutics International AB: what insiders have been doing
Guard Therapeutics International AB is a listed company. Its insiders report their share dealings to Finansinspektionen. The past year has been quiet: not a single insider filing for Guard Therapeutics International AB. The previous disclosure was published on 13 October 2020.
Since 2020, the database holds 4 purchases and no sales by insiders of the company.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Financial data
· cache
- 7,579 shares@ SEK 1.3047.9% of flowBTA (betald tecknad aktie)ISIN SE0014829867FI:csv-bb7869104fed14c23847Canonical exit: 11 Jan 2021 (T+90)
- 8,333 shares@ SEK 1.3052.1% of flowBTA (betald tecknad aktie)ISIN SE0014829867FI:csv-0248df27fba736906cc4Canonical exit: 31 Dec 2020 (T+90)
- 260,673 shares@ SEK 1.30100.0% of flowBTA (betald tecknad aktie)ISIN SE0014829867FI:csv-c2bdc7c64ace955e2f88Canonical exit: 31 Dec 2020 (T+90)
- 19,297 shares@ SEK 1.30100.0% of flowBTA (betald tecknad aktie)ISIN SE0014829867FI:csv-6d6d7082dd65dadd85ceCanonical exit: 27 Dec 2020 (T+90)
4 of 4 declarations
About Guard Therapeutics International AB
Guard Therapeutics International AB is a biopharmaceutical company focused on developing treatments for kidney diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations